Filing Flows › Precision Biosciences (DTIL) › R&D spending
Precision Biosciences (DTIL) R&D spending by quarter
Precision Biosciences' R&D spending was $13.1M in Q3 FY26 (third quarter fiscal 2026), -9% from Q2 FY26. Over the last 6 quarters it ranged from $12.8M (Q1 FY26) to $15.9M (Q2 FY25).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 FY26 | $13.1M | -9% | -4% |
| Q2 FY26 | $14.5M | +8% | -9% |
| Q1 FY26 | $13.4M | +5% | — |
| Q1 FY26 | $12.8M | -6% | — |
| Q3 FY25 | $13.6M | -15% | — |
| Q2 FY25 | $15.9M | — | — |
Q3 FY26 at a glance
Precision Biosciences, Q3 FY26: revenue $10.8M (374× year over year), operating margin -83.7%, net loss $18.4M, operating cash flow −$11.9M. The chart follows the revenue to costs, profit and cash.
Questions
What is Precision Biosciences' R&D spending?
Precision Biosciences' R&D spending was $13.1M in Q3 FY26 (third quarter fiscal 2026), -9% from Q2 FY26.
How has Precision Biosciences' R&D spending changed?
Over the last 6 quarters it ranged from $12.8M (Q1 FY26) to $15.9M (Q2 FY25).